ADHD Drug (unspecified)
Attention Deficit Hyperactivity Disorder
Key Facts
Indication
Attention Deficit Hyperactivity Disorder
Phase
ANDA Tentative Approval
Status
Approved/Tentative
Company
About Granules India
Granules India is a mission-driven pharmaceutical company focused on manufacturing high-quality, affordable essential medicines through a vertically integrated model. Its strategic achievements include establishing a global footprint with 10 manufacturing facilities, securing over 69 ANDA approvals, and serving 300+ customers in 80+ countries. The company's growth strategy is anchored in operational excellence, process innovation, and expanding its portfolio in complex generics and controlled substances to drive sustainable, profitable expansion.
View full company profileOther Attention Deficit Hyperactivity Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| ADHD Biomarker Program | Linus Biotechnology | Pre-clinical |
| ADHD Clinical Trials | Boston Clinical Trials | Not Specified (Typically Phase 2-3) |
| ADHD Stimulant APIs | Noramco | Commercial |